Naoki Inui
Pulmonology — Hamamatsu University Hospital, Japan
Naoki Inui
LeadR Profile
Pulmonology
Subspecialties: Oncology - Public Health - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 497
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Increased Risk of Thyrotoxicosis After COVID-19 in Adolescents and Young Adults During the Omicron-Predominant Period: A Nationwide Matched Study. thyroiditis, thyroiditis, subacute, thyroid gland, adolescent, covid-19, influenza, human, hypothyroidism, diagnosis, thyrotoxicosis | Clin Endocrinol (Oxf) | 2026 | 0 |
| Incidence of and Risk Factors for Immune Checkpoint Inhibitor-Related Pneumonitis in Thoracic Malignancies: A Prospective Multicenter Study. lung, incidence, neoplasms, drug therapy, immune checkpoint inhibitors, risk factors, therapeutics, history, smoking, chemotherapy | Oncologist | 2026 | 0 |
| Clinical utility of the geriatric nutritional risk index in patients with Mycobacterium avium complex lung disease: A multicenter retrospective study. mortality, confidence intervals, lung, mycobacterium avium, mycobacterium, retrospective studies, mycobacterium avium complex, lung diseases | Respir Investig | 2026 | 0 |
| Utility of serum Krebs von den Lungen-6 and surfactant protein D levels for differential diagnosis of immune checkpoint inhibitor-related pneumonitis. diagnosis, differential, serum, immunotherapy, immune checkpoint inhibitors, diagnosis, lung diseases, pulmonary surfactant-associated protein d, lung diseases, interstitial, sensitivity and specificity | Immunotherapy | 2026 | 0 |
| Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs. hypertension, pharmaceutical preparations, pulmonary arterial hypertension, pharmacology, bosentan, plasma, tadalafil | Br J Clin Pharmacol | 2026 | 1 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Beamion LUNG 1 A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) NCT04886804 — cells, genes, lung, genes, erbb-2, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, neoplasm metastasis, small cell lung carcinoma, therapeutics, carcinoma | Phase 1 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map